Table 5.
Tool | Acceptability | Feasibility | Reliability | Validity | Responsiveness |
---|---|---|---|---|---|
IPOS (original, patient version 1, 7-day recall) | +++ | +++ | 0 | 0 | 0 |
IPOS (Gemran, patient version, 3-day recall) | ++ | 0 | 0 | 0 | 0 |
GSF-PIG | 0 | 0 | 0 | 0 | 0 |
RADPAC | 0 | 0 | 0 | 0 | 0 |
SPICT | 0 | 0 | 0 | 0 | 0 |
SPICT (Japanese, SPICT-J) | 0 | 0 | 0 | 0 | 0 |
NAT:PD-HF (original) | + | +++ | + | ++ | 0 |
NAT:PD-HF (Dutch) | – | – | 0 | – | 0 |
NECPAL | 0 | 0 | 0 | 0 | 0 |
– = evidence does not support criteria
0 = not reported or no evidence in favor
+ = some limited evidence in favor
++ = some good evidence in favor, but some aspects do not meet criteria or some aspects not reported
+++ = good evidence in favor